Critical Warnings & Restrictions In Canada

Basic Eldepryl Information

• INN (International Nonproprietary Name): Selegiline.
• Brand Names Available In Canada (English): not specified.
• ATC Code: N04BD01.
• Forms & Dosages: Tablet 5 mg and 10 mg; Capsule 5 mg; Orally Disintegrating Tablet 1.25 mg (Zelapar); Transdermal Patch 6, 9, 12 mg/24hr (Emsam).
• Manufacturers In Canada (English): not specified.
• Registration Status In Canada (English): not specified.
• OTC / Rx Classification: Prescription only (Rx) in most jurisdictions.

High-Risk Groups (Elderly, Pregnant, Indigenous Health Considerations)

Are you worried this medicine might be unsafe for someone you care for?

Selegiline can cause serious cardiovascular, psychiatric and hypertensive reactions, so Health Canada–labelled guidance and local prescribers must be consulted before starting any therapy.

Older adults are often more sensitive to the side effects of MAO‑B inhibitors and need careful dose selection and monitoring to reduce risk of falls and confusion.

• Identified High-Risk Groups: Older adults (elderly).
• Identified High-Risk Groups: People who are pregnant or breastfeeding.
• Identified High-Risk Groups: People with severe cardiovascular disease or hypertension.
• Identified High-Risk Groups: People with psychosis, mania, or a history of severe mental illness.
• Identified High-Risk Groups: People using many medicines, including opioids and serotonergic antidepressants.
• Identified High-Risk Groups: Indigenous patients who use traditional medicines and need culturally safe care.

Monitoring Actions: Baseline and periodic blood pressure checks are essential because hypertensive events can be severe.

Monitoring Actions: Watch mental status closely for new agitation, hallucinations or mood changes that may require urgent review.

Monitoring Actions: Assess fall risk and orthostatic vitals when starting or increasing dose, particularly in the first weeks of therapy.

Monitoring Actions: Review all prescription medicines, over‑the‑counter products and supplements for interactions before initiating selegiline.

Monitoring Actions: Check hepatic function where clinically indicated because dose adjustments may be required in liver impairment.

Documentation Checklist For Shared Decision-Making And Consent: Record indication, expected benefits, known risks, alternative options, monitoring plan and patient or caregiver consent.

Interaction With Activities (Driving, Machinery, Workplace Safety Under Canadian Law)

Will selegiline affect the ability to drive or operate heavy equipment?

Dizziness, insomnia, blurred vision and hallucinations are known effects that may impair concentration and coordination while driving or using machinery.

Canadian employers, occupational health services and prescribers may recommend temporary work restrictions for safety‑sensitive roles such as commercial drivers, heavy equipment operators and public transit workers.

Follow this simple checklist before driving or using heavy machinery:

• No recent dose-related dizziness or lightheadedness within the last 24 hours.
• Normal standing and sitting blood pressure with no orthostatic symptoms.
• No new or worsening hallucinations, confusion or severe insomnia.
• If any of the above are present, do not drive and contact the prescriber or pharmacist.

Q&A — “Can I Drive After Taking It In Canada?”

Short Answer: Not until you know how selegiline affects you.

If you experience dizziness, sedation, orthostatic symptoms, blurred vision or hallucinations, do not drive.

Inform your prescriber and, if relevant, your insurer or employer according to occupational regulations.

Usage Basics For Canadians

INN, Brand Names Available In Canada

Which name will you see on the prescription or label?

INN → Selegiline.

Brands → Eldepryl, Zelapar, Emsam, and generic selegiline labels are listed in international supply information, though specific brand availability in Canada is not specified in the product data.

ATC → N04BD01 (MAO‑B inhibitor, anti‑Parkinson drug).

Confirm the exact product name, strength and packaging with your dispensing pharmacy and on your provincial drug formulary at the time of dispensing.

Legal Classification Under Health Canada (Prescription Vs OTC)

Do you need a prescription?

Selegiline is prescription‑only in most jurisdictions, and patients should expect a prescription for any approved oral or patch product.

• Obtain a valid prescription from an authorized prescriber before filling.
• Check the DIN on the label at dispensing to confirm the exact product supplied.
• Ask the pharmacist for the patient leaflet and bilingual labelling when required, especially in Quebec.
• Keep the prescription or pharmacist receipt for provincial reimbursement or private insurance claims.

Canadian Dosing Guide

Standard Regimens (Health Canada Approved)

What dose will most patients start on?

Typical adult Parkinson’s dosing is 5–10 mg daily, often given as 5 mg twice daily for tablets or capsules.

Orally disintegrating tablets (Zelapar) are commonly 1.25–2.5 mg once daily depending on the product strength.

Start at the lower end of the dose range in older adults and people with multiple medical issues to reduce side effect risk.

When used with levodopa/carbidopa, levodopa dosing may need review by the prescriber and pharmacist to optimise motor control.

Adjustments For Comorbidities (E.g., Diabetes, Common In Canadian Population)

How do other health conditions change the plan?

Hepatic impairment may reduce clearance and require lower doses with closer clinical monitoring.

Renal impairment is less likely to require specific dose changes, but monitor symptoms and overall clinical response.

People with diabetes should be counselled about orthostatic hypotension and fall risk, particularly if they use antihypertensives or other agents that affect blood pressure.

Recommended Clinic Follow‑Up Schedule: Baseline vitals and mood assessment before starting.

Recommended Clinic Follow‑Up Schedule: A 2–4 week check for orthostatic symptoms, fall risk, sleep disturbance and early adverse effects.

Recommended Clinic Follow‑Up Schedule: Ongoing reviews every three months once stable, or sooner if new symptoms develop.

Q&A — “What If I Miss A Dose Under My Provincial Drug Plan?”

Take the missed dose as soon as you remember unless it is almost time for the next dose.

Do not double the dose to make up for a missed one.

For coverage or refill problems, contact your provincial drug plan (for example Ontario Drug Benefit, BC PharmaCare, RAMQ) or speak with your dispensing pharmacy for interim supply or substitution options.

Interaction Chart (Canadian Context)

Food And Drinks (Coffee, Alcohol In Canadian Lifestyle)

Which foods and drinks should raise a flag?

Low‑dose MAO‑B inhibitors have a lower tyramine risk than nonselective MAOIs, but caution is warranted, particularly at higher doses or with transdermal formulations.

Large intakes of aged cheeses, certain cured meats and other high‑tyramine foods should be avoided when advised by the prescriber.

Alcohol and recreational drugs can increase orthostatic symptoms, sedation and fall risk and should be used cautiously.

Avoid meperidine and other contraindicated opioids because of severe interactions.

Common Drug Conflicts (Refer To Health Canada Advisories)

Which medicines are unsafe with selegiline?

• Other MAOIs — absolute contraindication due to hypertensive crisis risk.
• Certain antidepressants (SSRIs, SNRIs) — risk of serotonin syndrome when combined.
• Opioids such as meperidine — potentially life‑threatening reactions.
• Sympathomimetics (e.g., some decongestants) — can increase hypertensive risk.
• Over‑the‑counter cough suppressants containing dextromethorphan — check with the pharmacist first.

Bring all prescription medicines, over‑the‑counter products, herbal products and supplements to every appointment for a pharmacist review and interaction check.

User Reports & Trends In Canada

Canadian Patient Forums And Review Platforms

Where do patients share real‑world experience?

Patient forums such as Parkinson Canada discussion boards and provincial health forums can provide practical tips but may include unverified claims.

Triangulate forum information with Health Canada monographs and pharmacist counselling before acting on anecdotes.

• Credible Sources: Parkinson Canada.
• Credible Sources: Health Canada drug information pages.
• Credible Sources: Provincial health authority websites and accredited neurology centres.

Community Pharmacy Feedback

What do pharmacists see in daily practice?

Pharmacists commonly report that selegiline reduces “OFF” time when added to levodopa, while also noting insomnia and dizziness as frequent patient complaints.

Pharmacies perform medication reconciliation, counsel on food and drug interactions and help with generics or formulary substitutions.

Pharmacy Visit Checklist: Bring a current medication list and note any side effects or concerns to discuss with the pharmacist.

Access & Purchase Options

National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs, Jean Coutu)

Can large chains fill this prescription?

Most national chains will dispense prescription selegiline if they stock it or can order it for you.

Call ahead to confirm stock and estimated cost at your local store.

• Get a written prescription from your prescriber.
• Check the DIN and ask for the exact product dispensed.
• Ask about blister packaging or dose organisers for adherence support.

Online Pharmacies In Canada & Provincial Restrictions

Is it safe to order online?

Canadian‑licensed online pharmacies may dispense selegiline with a valid prescription; verify pharmacy licensing and the presence of a licensed pharmacist.

Do not import prescription medicines from unregulated international sellers without a prescription as customs and regulatory issues may apply.

Provincial formularies can require prior authorization or special authority for coverage under programs such as ODB, BC PharmaCare or RAMQ.

Safe Online Purchase Checklist: Verify pharmacy licence, ensure a valid prescription is required, confirm the DIN and check expiry dates on the package.

In our online pharmacy, eldepryl is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Mechanism & Pharmacology

Simplified Explanation (Patient-Friendly)

How does selegiline help in Parkinson’s disease?

Selegiline is an MAO‑B inhibitor that slows the breakdown of dopamine in the brain and helps reduce motor symptoms associated with Parkinson’s disease.

Benefits may appear over days to weeks, and the drug is often used long‑term to reduce motor fluctuations and delay increases in levodopa dosing.

Clinical Terms (Health Canada Approved Monograph References)

What do the clinical labels mean?

MAO‑B Inhibitor → An enzyme blocker that increases synaptic dopamine and helps manage Parkinson’s motor symptoms.

Adjunct Therapy → Used together with levodopa/carbidopa to improve motor control and reduce wearing‑off.

ODT → Orally disintegrating tablet useful for patients who have difficulty swallowing standard tablets or capsules.

Indications & Off-Label Uses In Canada

Approved Indications (DIN)

What is selegiline officially used for?

Primary indication: Adjuvant therapy in Parkinson’s disease to improve motor control and reduce wearing‑off effects when used with levodopa/carbidopa.

Confirm the product’s DIN and approved indications at dispensing; formulations and indications can differ between brands.

Selegiline is not recommended for paediatrics as use in children is not established.

Common Off-Label Practices (Canadian Physicians)

Are there other uses clinicians try?

Transdermal selegiline formulations have been used for depressive disorders in some jurisdictions, but this does not automatically apply to oral brands such as Eldepryl.

Off‑label use should involve specialist input and clear documentation of consent and monitoring plans.

• Prescriber Checklist For Off‑Label Use: Document indication, explain risks and alternatives, plan blood pressure monitoring and interaction checks, and involve pharmacy in reconciliation.

Key Clinical Findings

Canadian And International Studies 2022–2025

What does recent research say?

Recent literature through 2022–2025 supports selegiline’s role as an adjunct in early Parkinson’s to reduce motor fluctuations and delay levodopa escalation in suitable patients.

Safety reviews emphasise dose‑dependent neuropsychiatric effects in older adults and interaction risks with certain antidepressants and opioids.

Clinicians should consult up‑to‑date meta‑analyses and Health Canada advisories for detailed efficacy and safety data.

Ongoing Health Canada Safety Monitoring

How are side effects tracked in Canada?

Health Canada monitors adverse event reports and provides guidance; suspected adverse reactions should be reported through MedEffect Canada.

Action Checklist: Report severe or unexpected events to Health Canada, retain packaging with DIN and lot number, and contact local poison control for suspected overdose.

Alternatives Matrix

Comparable Medicines With DIN In Canada

Which drugs are commonly considered instead of or alongside selegiline?

Rasagiline is another MAO‑B inhibitor that generally offers once‑daily dosing and may be preferred for convenience.

Safinamide is a reversible MAO‑B inhibitor used as an adjunct in Parkinson’s therapy with a different interaction and side‑effect profile.

COMT inhibitors such as entacapone or tolcapone are adjuncts to levodopa for wearing‑off symptoms and may be used in combination with MAO‑B inhibitors under specialist guidance.

Pros And Cons Checklist

Which factors help choose an agent?

• Efficacy In Early Parkinson’s: Consider symptom control and impact on OFF time.
• Dosing Convenience: Once‑daily agents may improve adherence compared with twice‑daily regimens.
• Interaction Profile: Review serotonergic and opioid interactions carefully.
• Cost And Formulary Coverage: Check provincial plan restrictions and copays.
• Adverse Effect Profiles: Watch for insomnia, hallucinations and orthostatic hypotension especially in older adults.

Shared decision‑making with the prescriber and pharmacist is recommended when switching or combining therapies.

Common Questions From Canadian Patients

• “Is It Safe Long‑Term?” — Selegiline is often used long‑term with regular monitoring, periodic review for efficacy and adverse effects is required.
• “Will My Provincial Plan Cover It?” — Coverage varies by province and plan; check ODB, BC PharmaCare, RAMQ or private insurance and request prior authorization if required.
• “Can I Take Supplements/Herbs?” — Disclose all supplements and herbal products; St John’s Wort and products containing dextromethorphan can interact or increase risk of serotonin syndrome.
• “What About Cost And Generics?” — Generic selegiline may be available and can reduce cost; check with the pharmacy and provincial formulary for interchangeability and pricing.

Appointment Checklist: Bring a complete medication list, known allergies, recent blood pressure readings, provincial health card and specific questions about side effects or interactions.

Coverage & Purchase Comparison Table

Comparison Table — Province/Plan, Coverage Status, Typical Patient Cost, Prescription Required

This ready‑to‑fill table helps the content manager keep coverage information current; verify before publishing.

Step-By-Step Purchase Checklist For Canadian Patients

1. Obtain a valid prescription from an authorized prescriber.
2. Verify the DIN and exact product form required (tablet, ODT, patch).
3. Contact your preferred pharmacy to confirm stock and price.
4. Check your provincial plan for coverage rules, prior authorization or special authority requirements.
5. Arrange for adherence supports such as blister packs or dose organisers if needed.
6. Keep a record of lot number, expiry date and the patient information leaflet for reference.

Registration & Regulation

Health Canada Approval

Is this product regulated in Canada?

Selegiline products are regulated by national authorities and patients should confirm that their product has a valid DIN and approved labelling at dispensing.

Consult the Health Canada Drug Product Database or speak with the dispensing pharmacist to confirm the product’s approved monograph.

DIN Number And Labelling Requirements

What should you look for on the pack?

• Check the DIN to confirm the exact product dispensed.
• Ensure the label includes manufacturer details, lot number and expiry date.
• Request bilingual patient leaflets where applicable, especially in Quebec.
• Report missing safety information to the pharmacist and regulatory authorities if necessary.

Storage & Handling

Standard Canadian Household Conditions

How should you store it at home?

Store selegiline in the original packaging at room temperature below 25°C, away from moisture and light.

Do not refrigerate or freeze tablets, capsules or ODTs.

Keep all medicines out of reach of children and pets and do routine expiry checks.

Home Storage Checklist: Locked cabinet, original blister packaging, check expiry before use.

Cold-Chain Requirements (Where Applicable)

Does this product need refrigeration?

Oral tablets, capsules and ODTs do not require cold‑chain storage under normal conditions.

Transdermal patches should follow the manufacturer’s instructions, typically stored at room temperature and protected from excessive heat.

In Case Of Accidental Ingestion: Call your regional poison control centre or local emergency services immediately and retain the packaging for reference.

Guidelines For Proper Use

Canadian Pharmacist Guidance

What will the pharmacist do for you?

Pharmacists verify interactions, counsel on food cautions and side effects, confirm DIN and substitution options and provide adherence tools such as blister packs.

Pharmacists also document counselling in the patient profile and liaise with prescribers about dose adjustments and adverse events.

Provincial Health Authority Recommendations

Who sets the local rules?

Follow provincial formularies and special authority criteria for access and coverage.

Coordinate care with Parkinson Canada resources, local neurology clinics and provincial rehab services for multidisciplinary support.

Follow‑Up Visit Checklist For Patients: Bring a blood pressure log, a symptom diary noting motor ON/OFF times, side‑effect notes and a list of all healthcare providers involved in your care.

Delivery Across Canada (English)

Final Notes And Practical Tips

Which practical steps help manage therapy safely?

Always confirm the DIN and the product supplied at each refill and ask the pharmacist about interchangeability between brand and generic selegiline products.

Keep a simple symptom diary to track motor fluctuations, sleep patterns and any mood or behavioural changes after starting the medicine.

Carry an up‑to‑date medication list and notify all healthcare providers, including dental and emergency teams, that you are taking an MAO‑B inhibitor.

For suspected severe adverse events such as extreme hypertension, seizures, or profound agitation, seek immediate emergency care and bring the medication packaging for reference.

For non‑urgent questions, contact the dispensing pharmacist or the prescriber to arrange a medication review.